Health Canada drug identification number

DIN 02336847 — BESIVANCE 0.6 %

BESIVANCE is a suspension of Besifloxacin marketed by BAUSCH & LOMB INC. The full Besifloxacin monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02336847
Brand name
BESIVANCE
Active ingredient
Besifloxacin
Strength
0.6 %
Dosage form
SUSPENSION
Route
OPHTHALMIC
Manufacturer
BAUSCH & LOMB INC
Health Canada status
MARKETED
Drug class
Fluoroquinolone antibiotic (ophthalmic)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.